Scholarlink

Purpose of Review <p>In this review, we discuss the prevalence and reasons for such disparities, as well as the social determinants of health that compound such disparities and their effect on adverse cardiovascular outcomes. We also discuss factors contributing to these disparities and how to address them.</p> Recent Findings <p>Cardiovascular mortality has increased in the United States (US) since 2015 after 5 decades of decline, with a higher rate of increase in certain racial/ethnic groups compared to non-Hispanic Whites. (Tsao&#xa0;et al., Circulation. 2023;147:e93–621) There has also been a concomitant worsening of cardiovascular risk factor profiles in US adults (i.e., rising rates of hypertension, obesity, diabetes, and dyslipidemia). Despite recommendations for lipid screening by various health agencies and guidelines, screening rates remain suboptimal among non-Hispanic Black and Hispanic adults, especially in women. Significant disparities exist in lipid-lowering therapy (LLT) prescribing, initiation, dosing, and adherence. Several factors influence racial and gender disparities, including social determinants of health, clinician factors, and lack of culturally inclusive initiatives.</p> Summary <p>Although lipid management has improved over decades, racial and gender disparities still persist. In this review, we offer a few strategies to mitigate these disparities and discuss a toolkit that can be implemented to ensure equitable cardiovascular preventive care in all racial groups and sexes.</p> Graphical Abstract <p>Central Illustration: Strategies to address racial and ethnic disparities in atherosclerotic cardiovascular disease. The upper section of the figure presents various risk factors for atherosclerotic cardiovascular disease within vulnerable racial and ethnic populations. The lower segment of the figure shows strategies aimed at mitigating these racial/ethnic disparities in preventive therapies.</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Addressing Disparities in the Screening and Treatment of Dyslipidemia – A Call to Action

  • 期刊论文

  • 发表日期：

    2025年6月28日

查看全文
  • Emily Converse,
  • Karol Watson,
  • Zahid Ahmad,
  • Eugene Yang,
  • Eugenia Gianos,
  • Usman Sagheer,
  • Salim S. Virani,
  • Dinesh K. Kalra

摘要

Purpose of Review

In this review, we discuss the prevalence and reasons for such disparities, as well as the social determinants of health that compound such disparities and their effect on adverse cardiovascular outcomes. We also discuss factors contributing to these disparities and how to address them.

Recent Findings

Cardiovascular mortality has increased in the United States (US) since 2015 after 5 decades of decline, with a higher rate of increase in certain racial/ethnic groups compared to non-Hispanic Whites. (Tsao et al., Circulation. 2023;147:e93–621) There has also been a concomitant worsening of cardiovascular risk factor profiles in US adults (i.e., rising rates of hypertension, obesity, diabetes, and dyslipidemia). Despite recommendations for lipid screening by various health agencies and guidelines, screening rates remain suboptimal among non-Hispanic Black and Hispanic adults, especially in women. Significant disparities exist in lipid-lowering therapy (LLT) prescribing, initiation, dosing, and adherence. Several factors influence racial and gender disparities, including social determinants of health, clinician factors, and lack of culturally inclusive initiatives.

Summary

Although lipid management has improved over decades, racial and gender disparities still persist. In this review, we offer a few strategies to mitigate these disparities and discuss a toolkit that can be implemented to ensure equitable cardiovascular preventive care in all racial groups and sexes.

Graphical Abstract

Central Illustration: Strategies to address racial and ethnic disparities in atherosclerotic cardiovascular disease. The upper section of the figure presents various risk factors for atherosclerotic cardiovascular disease within vulnerable racial and ethnic populations. The lower segment of the figure shows strategies aimed at mitigating these racial/ethnic disparities in preventive therapies.